United Kingdom (UK) Parkinsons Disease Market (2025-2031) | Value, Forecast, Share, Growth, Segmentation, Trends, Industry, Competitive Landscape, Outlook, Size & Revenue, Analysis, Companies

Market Forecast By Drug Class (Levodopa/Carbidopa, Dopamine Receptor Agonists, MAO-Inhibitors, COMT-Inhibitors, Anticholinergics, Other Drugs), By Medical Devices (Deep Brain Stimulation (DBS) Devices, Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices), By Route of Administration (Oral, Transdermal, Subcutaneous, Intestinal Infusion, Others), By Distribution Channel (Hospital Pharmacies, Clinics, Retail Pharmacies, Online Pharmacies), By Patient Care Setting (Hospitals, Clinics) And Competitive Landscape
Product Code: ETC9951253 Publication Date: Sep 2024 Updated Date: Aug 2025 Product Type: Market Research Report
Publisher: 6Wresearch Author: Summon Dutta No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United Kingdom (UK) Parkinsons Disease Market Outlook
  • Market Size of United Kingdom (UK) Parkinsons Disease Market, 2024
  • Forecast of United Kingdom (UK) Parkinsons Disease Market, 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Revenues & Volume for the Period 2021- 2031
  • United Kingdom (UK) Parkinsons Disease Market Trend Evolution
  • United Kingdom (UK) Parkinsons Disease Market Drivers and Challenges
  • United Kingdom (UK) Parkinsons Disease Price Trends
  • United Kingdom (UK) Parkinsons Disease Porter's Five Forces
  • United Kingdom (UK) Parkinsons Disease Industry Life Cycle
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Drug Class for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Levodopa/Carbidopa for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Dopamine Receptor Agonists for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By MAO-Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By COMT-Inhibitors for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Anticholinergics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Other Drugs for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Medical Devices for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Deep Brain Stimulation (DBS) Devices for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Route of Administration for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Oral for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Transdermal for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Subcutaneous for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Intestinal Infusion for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Others for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Distribution Channel for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Hospital Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Retail Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Online Pharmacies for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Patient Care Setting for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Hospitals for the Period 2021- 2031
  • Historical Data and Forecast of United Kingdom (UK) Parkinsons Disease Market Revenues & Volume By Clinics for the Period 2021- 2031
  • United Kingdom (UK) Parkinsons Disease Import Export Trade Statistics
  • Market Opportunity Assessment By Drug Class
  • Market Opportunity Assessment By Medical Devices
  • Market Opportunity Assessment By Route of Administration
  • Market Opportunity Assessment By Distribution Channel
  • Market Opportunity Assessment By Patient Care Setting
  • United Kingdom (UK) Parkinsons Disease Top Companies Market Share
  • United Kingdom (UK) Parkinsons Disease Competitive Benchmarking By Technical and Operational Parameters
  • United Kingdom (UK) Parkinsons Disease Company Profiles
  • United Kingdom (UK) Parkinsons Disease Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6Wresearch actively monitors the United Kingdom (UK) Parkinsons Disease Market and publishes its comprehensive annual report, highlighting emerging trends, growth drivers, revenue analysis, and forecast outlook. Our insights help businesses to make data-backed strategic decisions with ongoing market dynamics. Our analysts track relevent industries related to the United Kingdom (UK) Parkinsons Disease Market, allowing our clients with actionable intelligence and reliable forecasts tailored to emerging regional needs.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United Kingdom (UK) Parkinsons Disease Market Overview

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) Parkinsons Disease Market - Industry Life Cycle

3.4 United Kingdom (UK) Parkinsons Disease Market - Porter's Five Forces

3.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Drug Class, 2021 & 2031F

3.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Medical Devices, 2021 & 2031F

3.7 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F

3.8 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.9 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume Share, By Patient Care Setting, 2021 & 2031F

4 United Kingdom (UK) Parkinsons Disease Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing aging population in the UK

4.2.2 Advances in medical research leading to better understanding and treatment of Parkinson's disease

4.2.3 Rising awareness and education about Parkinson's disease among healthcare professionals and the general public

4.3 Market Restraints

4.3.1 High costs associated with Parkinson's disease treatment and management

4.3.2 Limited accessibility to specialized healthcare services in certain regions of the UK

4.3.3 Potential side effects and risks associated with current Parkinson's disease medications

5 United Kingdom (UK) Parkinsons Disease Market Trends

6 United Kingdom (UK) Parkinsons Disease Market, By Types

6.1 United Kingdom (UK) Parkinsons Disease Market, By Drug Class

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Drug Class, 2021- 2031F

6.1.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Levodopa/Carbidopa, 2021- 2031F

6.1.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Dopamine Receptor Agonists, 2021- 2031F

6.1.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By MAO-Inhibitors, 2021- 2031F

6.1.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By COMT-Inhibitors, 2021- 2031F

6.1.7 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Anticholinergics, 2021- 2031F

6.1.8 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Other Drugs, 2021- 2031F

6.2 United Kingdom (UK) Parkinsons Disease Market, By Medical Devices

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Deep Brain Stimulation (DBS) Devices, 2021- 2031F

6.2.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Carbidopa/Levodopa Enteral Suspension (Duopa) Delivery Devices, 2021- 2031F

6.3 United Kingdom (UK) Parkinsons Disease Market, By Route of Administration

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Oral, 2021- 2031F

6.3.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Transdermal, 2021- 2031F

6.3.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Subcutaneous, 2021- 2031F

6.3.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Intestinal Infusion, 2021- 2031F

6.3.6 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Others, 2021- 2031F

6.4 United Kingdom (UK) Parkinsons Disease Market, By Distribution Channel

6.4.1 Overview and Analysis

6.4.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.4.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

6.4.4 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.4.5 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.5 United Kingdom (UK) Parkinsons Disease Market, By Patient Care Setting

6.5.1 Overview and Analysis

6.5.2 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Hospitals, 2021- 2031F

6.5.3 United Kingdom (UK) Parkinsons Disease Market Revenues & Volume, By Clinics, 2021- 2031F

7 United Kingdom (UK) Parkinsons Disease Market Import-Export Trade Statistics

7.1 United Kingdom (UK) Parkinsons Disease Market Export to Major Countries

7.2 United Kingdom (UK) Parkinsons Disease Market Imports from Major Countries

8 United Kingdom (UK) Parkinsons Disease Market Key Performance Indicators

8.1 Number of clinical trials and research studies focused on Parkinson's disease in the UK

8.2 Percentage increase in early diagnosis rates of Parkinson's disease

8.3 Adoption rate of new Parkinson's disease treatment guidelines by healthcare providers

9 United Kingdom (UK) Parkinsons Disease Market - Opportunity Assessment

9.1 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Drug Class, 2021 & 2031F

9.2 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Medical Devices, 2021 & 2031F

9.3 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Route of Administration, 2021 & 2031F

9.4 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.5 United Kingdom (UK) Parkinsons Disease Market Opportunity Assessment, By Patient Care Setting, 2021 & 2031F

10 United Kingdom (UK) Parkinsons Disease Market - Competitive Landscape

10.1 United Kingdom (UK) Parkinsons Disease Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) Parkinsons Disease Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Thought Leadership and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Related Reports

Industry Events and Analyst Meet

Whitepaper

Read All